Artrekas, UAB - company info and details

Company age: 5 y. 8 mo.

Update

Company overview

Company name Artrekas, UAB
Company code 305705985
Registered address Kretingos r. sav., Kretingos sen., Kvecių k., Ąžuolų g. 2, LT-97163
Registration date 2021-02-25 Company age: 5 y. 8 mo.
Phone Phone
Email Not disclosed (personal)
Website None
Company manager For registered members only Log in
Revenue (2025) 31,033 € +8% History
Profit (2025) -5,211 € History
Share capital 2,500 €
Number of employees 3 History
Managed vehicles 0
Current SODRA debt No debt Read more
Days of debt to SODRA per year 0 days
Current VMI debt No debt Read more
Financial statements All submitted
Legal form Private Limited Liability Company
NACE activity New construction
Ownership form Private without foreign capital

Description

This description was generated by artificial intelligence.
Artrekas, UAB is an operational private limited liability company registered on 25 February 2021. The company is a private entity owned under Lithuanian private ownership, with more than 50% of authorised capital held by Lithuanian natural and legal persons and no foreign investor capital. Governance is described as CEO only, and the company is classified as micro. Its main activity is coded F.41.00.10, New construction. The company is based in Kveciu k., Kretingos sen., Kretingos r. sav., Klaipedos apskr., Lithuania.

Financially, Artrekas, UAB remained a small business in 2025, generating revenue of EUR 31.0K, up 7.5% year on year and 22.9% over two years. After net profit of EUR 3.9K in 2023 and EUR 4.4K in 2024, the company reported a net loss of EUR 5.2K in 2025, with a negative profit margin of 16.8%. Equity declined to EUR 2.2K, liabilities increased to EUR 3.4K, and total assets stood at EUR 5.6K. The latest staff figure shows 1 average employee so far in 2026, after 2 average employees in both 2024 and 2025 and 1 in 2023.

Download a detailed company report

Make confident decisions with all the information about Artrekas, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.

19.99 € + PVM Get report